98 related articles for article (PubMed ID: 8089810)
1. Expression of a nuclear envelope protein recognized by the monoclonal antibody BU31 in lung tumours: relationship to Ki-67 antigen expression.
Rowlands DC; Bunce CM; Crocker J; Ayres JG; Johnson GD; Ling N; Brown G
J Pathol; 1994 Jun; 173(2):89-96. PubMed ID: 8089810
[TBL] [Abstract][Full Text] [Related]
2. Identification of the antigen recognized by the monoclonal antibody BU31 as lamins A and C.
Coates PJ; Hobbs RC; Crocker J; Rowlands DC; Murray P; Quinlan R; Hall PA
J Pathol; 1996 Jan; 178(1):21-9. PubMed ID: 8778310
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MIB-1 in neuroendocrine tumours of the lung.
Böhm J; Koch S; Gais P; Jütting U; Präuer HW; Höfler H
J Pathol; 1996 Apr; 178(4):402-9. PubMed ID: 8691318
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in proliferation markers in colorectal cancer.
Kressner U; Lindmark G; Gerdin B; Pahlman L; Glimelius B
Anticancer Res; 1995; 15(6B):2755-61. PubMed ID: 8669859
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in non small cell lung cancer: clinical and biological correlations.
Fontanini G; Bigini D; Vignati S; Macchiarini P; Pepe S; Angeletti CA; Pingitore R; Squartini F
Anticancer Res; 1993; 13(3):737-42. PubMed ID: 8100413
[TBL] [Abstract][Full Text] [Related]
8. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
9. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
10. c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data.
Devictor B; Bonnier P; Piana L; Andrac L; Lavaut MN; Allasia C; Charpin C
Gynecol Oncol; 1993 Jun; 49(3):284-90. PubMed ID: 8390959
[TBL] [Abstract][Full Text] [Related]
11. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas.
Sabattini E; Gerdes J; Gherlinzoni F; Poggi S; Zucchini L; Melilli G; Grigioni F; Del Vecchio MT; Leoncini L; Falini B
J Pathol; 1993 Apr; 169(4):397-403. PubMed ID: 8099126
[TBL] [Abstract][Full Text] [Related]
13. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
15. Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer.
Ishiwata N; Jinn Y; Tsukada Y; Inase N; Ichioka M; Yoshizawa Y
Anticancer Res; 2000; 20(3A):1445-50. PubMed ID: 10928055
[TBL] [Abstract][Full Text] [Related]
16. Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen.
Szeremeta W; Monsell EM; Rock JP; Caccamo DV
Am J Otol; 1995 Sep; 16(5):616-9. PubMed ID: 8588666
[TBL] [Abstract][Full Text] [Related]
17. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
18. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7).
Guillaud P; du Manoir S; Seigneurin D
Anal Cell Pathol; 1989 Feb; 1(1):25-39. PubMed ID: 2488698
[TBL] [Abstract][Full Text] [Related]
19. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
20. Identification of proliferating cells by Ki-67 antibody.
Baisch H; Gerdes J
Methods Cell Biol; 1990; 33():217-26. PubMed ID: 2084469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
